USPTO 2015–2025 USPTO PatentsView US Corporation

Intact Vascular, Inc.

USPTO PatentsView assignee record - 41 granted patents across 4 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

RSS updates for this company

The verdict

According to USPTO PatentsView, Intact ranks #7,863 of 49,997 tracked US assignees by granted-patent volume, with 41 patents across 4 technology areas.

#7,863
of 49,997 US assignees by volume
45th percentile
by Innovation Score (33.6/100)
20.9
avg claims per patent
-54%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R7863 · US Corporation #7,863 · 41 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-DROP · BOOK-FULL

  • GRANTS-SMALL 41 grants
  • UPPER-Q #7,863/49,997
  • PHOTO-FINISH Honeywell
  • CPC-NARROW A61F · 4 areas
  • INNOV-THIN 33.6/100
  • CLAIMS-DENSE 20.9 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-DROP -54% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Honeywell Limited (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Intact’s 33.6 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Intact

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Intact's Innovation Score is 33.6/100 (45th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Intact?

Each dot is one of Intact’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Intact’s own 20.9 claims/patent is ABOVE the 13.6 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Intact vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 40.941.041.04141.041.041.1 510152025 Granted patents (volume) Avg claims / patent Honeywell Limited - 41, 18.17HoneywellHuami Inc. - 41, 10.29HuamiInha University Research AND Business Foundation - 41, 12.24Inha University R…Institute OF Physics, THE Chinese Academy OF Sciences - 41, 13.59Institute OF Phys…Iwis Motorsysteme GMBH & Co. KG - 41, 14.9Iwis Motorsysteme…Imerys USA, Inc. - 41, 15.61Imerys USAImpossible Foods Inc. - 41, 19.76Impossible FoodsInventec Appliances (Shanghai) Co., Ltd. - 41, 11.15Inventec Applianc…Intact Vascular, Inc. - 41, 20.93Intact Vascular
Intact vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Intact's grants concentrate

Intact Vascular, Inc. is a focused PatentsView assignee: 4 CPC subclasses with 97.6% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2016 (8 grants) versus a trough of 1 in 2015. By volume, Intact sits between Honeywell Limited and Inventec Appliances (Shanghai) Co., Ltd..

Intact's three-year grant acceleration

Intact Vascular, Inc. shows 3 grants in 2022–2024 against only 18 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Intact's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Intact holds 41 patents at rank #7,861, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Intact

By rank, the assignees closest to #7,861 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in Intact's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Intact, neither rank-band nor same-CPC leaders (those blocks stay above). In A61F (Filters Implantable Into Blood Vessels), Intact ranks #156 of 3,082 assignees by patent count in that subclass.

Intact's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

34 45th percentile higher than 45% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0246810 2015201620172018201920202021202220232024 1
USPTO utility patent grants by year · 2015–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Intact Vascular, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 1 2.4%
2016 8 19.5%
2017 7 17.1%
2018 4 9.8%
2019 8 19.5%
2020 7 17.1%
2021 3 7.3%
2022 1 2.4%
2023 1 2.4%
2024 1 2.4%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Intact Vascular, Inc.'s patent record in context - here's where to go next.

  • Intact Vascular, Inc.'s lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 97.6% of its portfolio - see every assignee active in that class. Explore A61F
  • Ranked #7,863 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Intact Vascular, Inc. against Honeywell Limited, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 33.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.